Study on the Potential Mechanism of Semen Strychni against Myasthenia Gravis Based on Network Pharmacology and Molecular Docking with Experimental Verification

Table 3

Vina affinity of ingredient-target docking.

Compound	Affinity (kcal/mol)
	AKT1	MAPK1	MAPK14	CHRM1	ACHE	CHRNA4
Isobrucine	−6.8	/	−7.6	−7.4	/	−8.2
Vomicine	−8.3	/	/	−8.6	/	−9.1
(S)-Stylopine	/	−8.9	/	−8.3	−8.3	−9.6
Strychnine	/	/	−9.1	/	/	−9.7
Brucine-N-oxide	/	/	−8.5	/	/	−9.1
Brucine	/	/	/	−7.5	/	/

/: means did not analyze.